Ropeginterferon alfa-2b
Ropeginterferon alfa-2b | |
---|---|
Term | Ropeginterferon alfa-2b |
Short definition | Ropeginterferon alfa-2b - (pronounced) (raw-peg-IN-ter-FEER-on AL-fuh. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Ropeginterferon alfa-2b - (pronounced) (raw-peg-IN-ter-FEER-on AL-fuh. . . ) A medicine used to treat adults with polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also being studied in the treatment of other conditions and some types of cancer. Ropeginterferon alfa-2b is a form of recombinant interferon alfa-2b that's made in a laboratory and linked to a substance called PEG, which allows the drug to stay in the body longer. Ropeginterferon alfa-2b can reduce the number of red blood cells made in the bone marrow. It's a type of cytokine and a type of immunomodulating agent. Also called Besremi
External links
- Medical encyclopedia article on Ropeginterferon alfa-2b
- Wikipedia's article - Ropeginterferon alfa-2b
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski